Cogent Biosciences, Inc. COGT Increase Decrease In Operating Leases
Increase Decrease In Operating Leases at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept cogt:IncreaseDecreaseInOperatingLeases.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s increase decrease in operating leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s increase decrease in operating leases?
- Cogent Biosciences, Inc. (COGT) reported increase decrease in operating leases of -$422K in Q1 2026.
- How has Cogent Biosciences, Inc.'s increase decrease in operating leases changed year-over-year?
- Cogent Biosciences, Inc.'s increase decrease in operating leases decreased by 12.2% year-over-year, from -$376K to -$422K.
- What is the long-term trend for Cogent Biosciences, Inc.'s increase decrease in operating leases?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s increase decrease in operating leases has grown at a -6.5% compound annual growth rate (CAGR), from -$2.05M to -$1.57M.
- What does increase decrease in operating leases mean?
- Captures the net change in operating lease liabilities resulting from lease payments and the recognition of new lease obligations. This metric is critical for evaluating how lease-related cash outflows impact the company's overall operating cash flow. It provides transparency into the company's fixed commitment obligations for facilities and equipment.